All Title Author
Keywords Abstract

Participation of 5-HT and AT1 Receptors within the Rostral Ventrolateral Medulla in the Maintenance of Hypertension in the Goldblatt 1 Kidney-1 Clip Model

DOI: 10.1155/2014/723939

Full-Text   Cite this paper   Add to My Lib


The hypothesis that changes in neurotransmission within the rostral ventrolateral medulla (RVLM) are important to maintain the high blood pressure (BP) was tested in Goldblatt one kidney-one clip hypertension model (1K-1C). Male Wistar rats were anesthetized (urethane 1.2?g/kg, i.v.), and the effects of bilateral microinjections into the RVLM of the following drugs were measured in 1K-1C or control groups: glutamate (0.1?mol/L, 100?nL) and its antagonist kynurenic acid (0.02?mol/L, 100?nL), the angiotensin AT1 receptor antagonist candesartan (0.01?mol/L, 100?nL), and the nonselective 5-HT receptor antagonist methiothepin (0.06?mol/L, 100?nL). Experiments in 1K-1C rats were performed 6 weeks after surgery. In anesthetized rats glutamate response was larger in hypertensive than in normotensive rats (H: ; N: ?mmHg). In contrast, kynurenic acid microinjection into the RVLM did not cause any change in BP in either group. The blockade of either AT1 or 5-HT receptors within the RVLM decreased BP only in 1K-1C rats. A largest depressor response was caused by 5-HT receptor blockade. The data suggest that 5-HT and AT1 receptors act tonically to drive RVLM in 1K-1C rats, and these actions within RVLM contribute to the pathogenesis of this model of hypertension. 1. Introduction The importance of sympathetic nervous system activation in the pathogenesis of hypertension has been demonstrated, and the therapeutic value of sympathetic nervous inhibition in hypertensive patients is already evident and has been widely studied [1]. Ongoing activity of premotor rostral ventrolateral medulla (RVLM) neurons is responsible for the tonic generation of sympathetic vasomotor tone; inhibition of RVLM neurons causes a large decrease in both arterial blood pressure (BP) and sympathetic nervous system activity, while stimulation of this medullary region increases sympathetic vasomotor outflow and BP [2, 3]. Therefore, changes in the local neurotransmission within the RVLM can be a mechanism involved in the sympathetic activation in hypertension. Previous studies demonstrated that microinjection into the RVLM of excitatory amino acid (EAA) receptor antagonists has no effect on basal level of BP [4]. This fact has been interpreted as suggesting that the ongoing RVLM activity is not dependent on EAA inputs to the RVLM. However, we showed previously that, in Goldblatt 2-kidneys, one-clip (2K1C) model, microinjection of kynurenic acid, a broad spectrum EAA receptor antagonist, into the RVLM, reduced BP to the same extent as autonomic blockade [5]. Similar results were later shown in SHR


[1]  S. Laurent, M. Schlaich, and M. Esler, “New drugs, procedures, and devices for hypertension,” The Lancet, vol. 380, no. 9841, pp. 591–600, 2012.
[2]  R. A. L. Dampney, “The subretrofacial vasomotor nucleus: anatomical, chemical and pharmacological properties and role in cardiovascular regulation,” Progress in Neurobiology, vol. 42, no. 2, pp. 197–227, 1994.
[3]  P. G. Guertzenstein and A. Silver, “Fall in blood pressure produced from discrete regions of the ventral surface of the medulla by glycine and lesions,” Journal of Physiology, vol. 242, no. 2, pp. 489–503, 1974.
[4]  M.-K. Sun and P. G. Guyenet, “Arterial baroreceptor and vagal inputs to sympathoexcitatory neurons in rat medulla,” The American Journal of Physiology, vol. 252, no. 4, part 2, pp. R699–R709, 1987.
[5]  C. Bergamaschi, R. R. Campos, N. Schor, and O. U. Lopes, “Role of the rostral ventrolateral medulla in maintenance of blood pressure in rats with Goldblatt hypertension,” Hypertension, vol. 26, no. 6, pp. 1117–1120, 1995.
[6]  S. Ito, K. Komatsu, K. Tsukamoto, and A. F. Sved, “Excitatory amino acids in the rostral ventrolateral medulla support blood pressure in spontaneously hypertensive rats,” Hypertension, vol. 35, no. 1, pp. 413–417, 2000.
[7]  J. W. Osborn, J. P. Collister, and S. H. Carlson, “Angiotensin and osmoreceptor inputs to the area postrema: role in long-term control of fluid homeostasis and arterial pressure,” Clinical and Experimental Pharmacology and Physiology, vol. 27, no. 5-6, pp. 443–449, 2000.
[8]  G. D. Fink, C. A. Bruner, and M. L. Mangiapane, “Area postrema is critical for angiotensin-induced hypertension in rats,” Hypertension, vol. 9, no. 4, pp. 355–361, 1987.
[9]  S. Ito, M. Hiratsuka, K. Komatsu, K. Tsukamoto, K. Kanmatsuse, and A. F. Sved, “Ventrolateral medulla AT1 receptors support arterial pressure in Dahl salt-sensitive rats,” Hypertension, vol. 41, no. 3, part 2, pp. 744–750, 2003.
[10]  T. Tagawa and R. A. L. Dampney, “AT1 receptors mediate excitatory inputs to rostral ventrolateral medulla pressor neurons from hypothalamus,” Hypertension, vol. 34, no. 6, pp. 1301–1307, 1999.
[11]  A. G. Ramage, “Central cardiovascular regulation and 5-hydroxytryptamine receptors,” Brain Research Bulletin, vol. 56, no. 5, pp. 425–439, 2001.
[12]  Z. Yang, D. Bertram, and J. H. Coote, “The role of glutamate and vasopressin in the excitation of RVL neurones by paraventricular neurones,” Brain Research, vol. 908, no. 1, pp. 99–103, 2001.
[13]  T. Tsuchihashi, S. Kagiyama, Y. Ohya, I. Abe, and M. Fujishima, “Antihypertensive treatment and the responsiveness to glutamate in ventrolateral medulla,” Hypertension, vol. 31, no. 1, pp. 73–76, 1998.
[14]  S. Morimoto, S. Sasaki, S. Miki et al., “Pressor response to compression of the ventrolateral medulla mediated by glutamate receptors,” Hypertension, vol. 33, no. 5, pp. 1207–1213, 1999.
[15]  D. B. Averill, T. Tsuchihashi, M. C. Khosla, and C. M. Ferrario, “Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla,” Brain Research, vol. 665, no. 2, pp. 245–252, 1994.
[16]  A. M. Allen, “Blockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 2, no. 1, pp. S120–S124, 2001.
[17]  G. F. DiBona and S. Y. Jones, “Sodium intake influences hemodynamic and neural responses to angiotensin receptor blockade in rostral ventrolateral medulla,” Hypertension, vol. 37, no. 4, pp. 1114–1123, 2001.
[18]  S. Ito, K. Komatsu, K. Tsukamoto, K. Kanmatsuse, and A. F. Sved, “Ventrolateral medulla AT1 receptors support blood pressure in hypertensive rats,” Hypertension, vol. 40, no. 4, pp. 552–559, 2002.
[19]  R. R. Campos, E. B. Oliveira-Sales, é. E. Nishi, M. A. Boim, M. S. Dolnikoff, and C. T. Bergamaschi, “The role of oxidative stress in renovascular hypertension,” Clinical and Experimental Pharmacology and Physiology, vol. 38, no. 2, pp. 144–152, 2011.
[20]  A. M. Allen, “Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone,” Hypertension, vol. 39, no. 2, pp. 275–280, 2002.
[21]  S. Azar, P. Ernsberger, and S. Livingston, “Paraventricular-suprachiasmatic lesions prevent salt induced hypertension in Dahl rats,” Clinical Science, vol. 61, supplement 7, pp. 49s–51s, 1981.
[22]  J. R. Haywood, S. W. Mifflin, T. Craig, A. Calderon, J. G. Hensler, and C. Hinojosa-Laborde, “γ-Aminobutyric acid (GABA)-A function and binding in the paraventricular nucleus of the hypothalamus in chronic renal-wrap hypertension,” Hypertension, vol. 37, no. 2, part 2, pp. 614–618, 2001.
[23]  A. Lippoldt, M. Paul, K. Fuxe, and D. Ganten, “The brain renin-angiotensin system: molecular mechanisms of cell to cell interaction,” Clinical and Experimental Hypertension, vol. 17, no. 1-2, pp. 251–266, 1995.
[24]  I. K. Anderson, G. R. Martin, and A. G. Ramage, “Evidence that activation of 5-HT2 receptors in the forebrain of anaesthetized cats causes sympathoexcitation,” British Journal of Pharmacology, vol. 116, no. 2, pp. 1751–1756, 1995.
[25]  A. K. Mandal, K. J. Kellar, W. P. Norman, and R. A. Gillis, “Stimulation of serotonin2 receptors in the ventrolateral medulla of the cat results in nonuniform increases in sympathetic outflow,” Circulation Research, vol. 67, no. 5, pp. 1267–1280, 1990.
[26]  R. B. McCall and M. E. Clement, “Role of serotonin1A and serotonin2 receptors in the central regulation of the cardiovascular system,” Pharmacological Reviews, vol. 46, no. 3, pp. 231–243, 1994.
[27]  R. R. Campos Jr., H. A. Futuro-Neto, and P. G. Guertzenstein, “Role of the rostral ventrolateral medulla in the pressor response to stimulation of the nucleus raphe obscurus,” Brazilian Journal of Medical and Biological Research, vol. 26, no. 6, pp. 623–631, 1993.


comments powered by Disqus